Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
Launched by MEDICAL UNIVERSITY OF GRAZ · Apr 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of acupuncture as part of a comprehensive treatment plan for women suffering from vulvodynia and chronic pelvic pain (CPP). Vulvodynia is a condition that causes discomfort or pain in the vulva, while CPP refers to ongoing pain in the pelvic area. The goal of the study is to see if acupuncture can help reduce pain and improve quality of life for these women.
To participate in the trial, women aged 18 to 75 who have experienced vulvodynia or CPP for at least six months and have been receiving multidisciplinary treatment for at least three months may be eligible. Participants will be randomly assigned to either receive acupuncture or be placed on a waiting list for the treatment. Throughout the study, participants will report their pain levels and complete questionnaires to assess their overall well-being. This research is currently recruiting participants, and it aims to provide valuable insights into the effectiveness of acupuncture for these painful conditions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with vulvodynia and/or chronic pelvic pain of at least 6 months duration
- • multidisciplinary treatment for at least 3 months
- Exclusion Criteria:
- • Pregnancy
- • Current malignancy
- • Major neurologic or psychiatric morbidity
- • Study participation in Lydia trial (Lasertherapy for vulvodynia)
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials